NCT06450353 Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
| NCT ID | NCT06450353 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Allogeneic Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2024-05-31 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2024-05-31 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).
Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years of age. 2. Candidate for allogeneic transplantation Exclusion Criteria: 1\) Allogeneic stem cell transplantation not medically indicated.
Contact & Investigator
Warren Fingrut, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06450353 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Allogeneic Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06450353 currently recruiting?
Yes, NCT06450353 is actively recruiting participants. Contact the research team at wbfingrut@mdanderson.org for enrollment information.
Where is the NCT06450353 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06450353 clinical trial?
NCT06450353 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Warren Fingrut, MD at M.D. Anderson Cancer Center. The trial plans to enroll 1,200 participants.